LifeVantage Corp
NASDAQ:LFVN
Intrinsic Value
LifeVantage Corp. engages in the identification, research, development and distribution of advanced nutraceutical dietary supplements and personal care products. [ Read More ]
The intrinsic value of one LFVN stock under the Base Case scenario is 10.7 USD. Compared to the current market price of 6.24 USD, LifeVantage Corp is Undervalued by 42%.
Valuation Backtest
LifeVantage Corp
Run backtest to discover the historical profit from buying and selling LFVN stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
LifeVantage Corp
Current Assets | 38.7m |
Cash & Short-Term Investments | 17.3m |
Receivables | 2.6m |
Other Current Assets | 18.8m |
Non-Current Assets | 24m |
PP&E | 18.5m |
Intangibles | 389k |
Other Non-Current Assets | 5.1m |
Current Liabilities | 23m |
Accounts Payable | 6.2m |
Accrued Liabilities | 16m |
Other Current Liabilities | 825k |
Non-Current Liabilities | 12.4m |
Other Non-Current Liabilities | 12.4m |
Earnings Waterfall
LifeVantage Corp
Revenue
|
210.9m
USD
|
Cost of Revenue
|
-42.9m
USD
|
Gross Profit
|
168m
USD
|
Operating Expenses
|
-164.3m
USD
|
Operating Income
|
3.7m
USD
|
Other Expenses
|
-725k
USD
|
Net Income
|
3m
USD
|
Free Cash Flow Analysis
LifeVantage Corp
LFVN Profitability Score
Profitability Due Diligence
LifeVantage Corp's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
LifeVantage Corp's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
LFVN Solvency Score
Solvency Due Diligence
LifeVantage Corp's solvency score is 72/100. The higher the solvency score, the more solvent the company is.
Score
LifeVantage Corp's solvency score is 72/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
LFVN Price Targets Summary
LifeVantage Corp
According to Wall Street analysts, the average 1-year price target for LFVN is 7 USD .
Ownership
LFVN Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
LFVN Price
LifeVantage Corp
Average Annual Return | -18.51% |
Standard Deviation of Annual Returns | 36.93% |
Max Drawdown | -82% |
Market Capitalization | 80.4m USD |
Shares Outstanding | 12 868 500 |
Percentage of Shares Shorted | 0.54% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
LifeVantage Corp. engages in the identification, research, development and distribution of advanced nutraceutical dietary supplements and personal care products. The company is headquartered in Lehi, Utah and currently employs 160 full-time employees. The company went IPO on 2012-09-12. Its products include Protandim, LifeVantage Omega+, ProBio and Daily Wellness dietary supplements, TrueScience, Axio and PhysIQ. LifeVantage Omega+ is a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and Vitamin D3 to support cognitive health, cardiovascular health, skin health, and the immune system. ProBio is a dietary supplement designed to support optimal digestion and immune system function. Daily Wellness is a dietary supplement designed to support and strengthen immune health. TrueScience, which consists of facial cleanser, perfecting lotion, eye serum. PhysIQ, which consists of fat burn, prebiotic and whey protein.
Contact
IPO
Employees
Officers
The intrinsic value of one LFVN stock under the Base Case scenario is 10.7 USD.
Compared to the current market price of 6.24 USD, LifeVantage Corp is Undervalued by 42%.